BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 24656909)

  • 1. Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis.
    Kuriyama A; Honda M; Hayashino Y
    Sleep Med; 2014 Apr; 15(4):385-92. PubMed ID: 24656909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis.
    Wang-Weigand S; McCue M; Ogrinc F; Mini L
    Curr Med Res Opin; 2009 May; 25(5):1209-13. PubMed ID: 19327100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ramelteon for the treatment of insomnia.
    Borja NL; Daniel KL
    Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.
    Mini L; Wang-Weigand S; Zhang J
    Clin Ther; 2008 Jul; 30(7):1316-23. PubMed ID: 18691991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.
    Roth T; Seiden D; Wang-Weigand S; Zhang J
    Curr Med Res Opin; 2007 May; 23(5):1005-14. PubMed ID: 17519067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramelteon: a novel approach in the treatment of insomnia.
    Reynoldson JN; Elliott E; Nelson LA
    Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis.
    Liu J; Wang LN
    Int J Clin Pract; 2012 Sep; 66(9):867-73. PubMed ID: 22897464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of melatonin and ramelteon for the acute and long-term management of insomnia disorder in adults: A systematic review and meta-analysis.
    Maruani J; Reynaud E; Chambe J; Palagini L; Bourgin P; Geoffroy PA
    J Sleep Res; 2023 Dec; 32(6):e13939. PubMed ID: 37434463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
    Mayer G; Wang-Weigand S; Roth-Schechter B; Lehmann R; Staner C; Partinen M
    Sleep; 2009 Mar; 32(3):351-60. PubMed ID: 19294955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ; Wang-Weigand S; Zhang J
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
    Wang-Weigand S; Watissée M; Roth T
    Sleep Med; 2011 Oct; 12(9):920-3. PubMed ID: 21925941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study.
    Richardson GS; Zammit G; Wang-Weigand S; Zhang J
    J Clin Psychiatry; 2009 Apr; 70(4):467-76. PubMed ID: 19284927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study.
    Uchimura N; Ogawa A; Hamamura M; Hashimoto T; Nagata H; Uchiyama M
    Expert Rev Neurother; 2011 Feb; 11(2):215-24. PubMed ID: 21306209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramelteon: new drug. Insomnia: no role for risky placebos.
    Prescrire Int; 2008 Oct; 17(97):183-6. PubMed ID: 19534018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ramelteon.
    McGechan A; Wellington K
    CNS Drugs; 2005; 19(12):1057-65; discussion 1066-7. PubMed ID: 16332146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ramelteon: a review of its use in insomnia.
    Simpson D; Curran MP
    Drugs; 2008; 68(13):1901-19. PubMed ID: 18729542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of ramelteon in a first-night model of transient insomnia.
    Zammit G; Schwartz H; Roth T; Wang-Weigand S; Sainati S; Zhang J
    Sleep Med; 2009 Jan; 10(1):55-9. PubMed ID: 18691937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia.
    Uchiyama M; Hamamura M; Kuwano T; Nishiyama H; Nagata H; Uchimura N
    Sleep Med; 2011 Feb; 12(2):119-26. PubMed ID: 21256803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M; Seiden D; Zammit G; Sainati S; Zhang J
    Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.